DHCR7 and Smith-Lemli-Opitz syndrome: The loss of DHCR7 enzymatic activity in Dhcr7ΔEx8/ΔEx8 mice and SLOS patients has been shown to result in reduced levels of cellular cholesterol (53,79), prompting us to investigate whether reduced cholesterol levels underlie the defective SMO activation we observed.